GHK-Cu vs Epithalon
A comprehensive, data-driven comparison of GHK-Cu (Copper Peptide) and Epithalon (Epitalon). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | GHK-Cu Copper Peptide, GHK-Copper | Epithalon Epitalon, Epithalone |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Anti-Aging | Anti-Aging |
| Primary Use | Skin rejuvenation and anti-aging | Anti-aging and longevity research |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $150/mo | $40 - $80/mo |
| Administration | Topical | Subcutaneous injection |
| Typical Dose | 1-2% topical cream daily, or 1-2mg injection | 5-10mg per cycle (10-20 days, 2-3x per year) |
| Frequency | Daily | Cyclical |
| Mechanism | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Epithalon is generally more affordable ($40 - $80/mo) compared to GHK-Cu ($30 - $150/mo).
- 2GHK-Cu is administered via topical, while Epithalon uses subcutaneous injection.
- 3GHK-Cu is dosed daily, while Epithalon is cyclical.
- 4GHK-Cu has moderate-quality evidence, while Epithalon has emerging-quality evidence.
Which Is Better For...
Epithalon
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
GHK-Cu
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. They differ in FDA approval status, efficacy data, and cost.
GHK-Cu typically costs $30 - $150/mo, while Epithalon costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
GHK-Cu is not FDA-approved (Not submitted). Epithalon is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuideEpithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between GHK-Cu and Epithalon should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.